Although EpoR76E treatment did not restore all normal functions in 5xFAD mice, it protected against cognitive impairment, presumably by promoting the maintenance of synaptic clefts and reducing Aβ-associated toxicity, possibly by reducing expression of the β-secretase BACE1. The gene discussed is BACE1; the disease is Cognitive impairment.